{"database": "openregs", "table": "dockets", "rows": [["FDA-2004-P-0401", "FDA", "Request the Commissioner of Food and Drugs re-evaluate FDA's policy concerning the marketing of 'authorized generic' versions of brand name prescription drugs. - CLOSED", "Nonrulemaking", "2021-09-01T01:02:20Z", "0b000064804744cc"]], "columns": ["id", "agency_id", "title", "docket_type", "last_modified", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-2004-P-0401"], "units": {}, "query_ms": 0.2813440514728427, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}